Without resting on its laurels of demonstrating unmatched quality in manufacturing drugs for the domestic market, Nysa Biomed has persistently sought to enter new, emerging as well as developed markets throughout the world. Further raising the quality bar & meeting the stringent standards as required by foreign drug regulatory bodies has enabled forays into multiple countries spread across Latin America, Central – West & North Africa, South East Asian Countries.
Our goal of helping humankind live well is not confined to just our domestic market and therefore we are continuously working on expanding the reach of the company so that our life-saving drugs can reach as many people as possible and at competitive prices. Deeper penetration into highly regulated markets such as Europe, GCC, MENA, Russia and CIS Countries, Latin America and WHO-Geneva remains our key goals. The distinguished quality assurance system put in place by Nysa Biomed will allow for the same in the near future.